Innovent Biologics, Inc.

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023🗂️ Report periods on file: 2023

In its 2023 reporting, Innovent Biologics, Inc. disclosed greenhouse gas emissions of 15.9K tCO2e/year. By scope: Scope 1: 65.17 tCO2e/year; Scope 2: 15.8K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
15.9K tCO2e/year
2023
💧
Water Usage
666.0K m3/year
2023
♻️
Waste
693.1 tons/year
2023
⚙️
Energy Use
4.9K tons of standard coal/year
2023

📊 Emissions by Scope (2023)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).65.17 tCO2e/year
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.15.8K tCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

📅 Medium-term

  • Achieve a 5% annual reduction in annual fresh water use per production unit by 2030
  • Achieve an annual 5% reduction in hazardous waste generation per unit of product by 2030
  • Reduce GHG emissions per unit of product by 10% by 2030 compared to 2020
  • Achieve a 30% reduction in air emission generation by 2030 as compared to 2022
  • Achieve a 5% annual reduction in energy consumption per production unit by 2030

🌱 ESG Focus Areas

Excellent GovernanceEnjoying Good HealthHigh Quality as KeyPeople FirstEmbracing Ecology

⚠️ Challenges & Risks +

  • Transition costs of low-emission carbon technology
  • Increase of average temperature
  • Extreme weather

📋 Report Information

Reporting Period: 2023
Frameworks: SEHK ESG Reporting Guide, MSCI ESG Ratings